Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review

C Viegas, AB Patrício, JM Prata, A Nadhman… - Pharmaceutics, 2023 - mdpi.com
Solid–lipid nanoparticles and nanostructured lipid carriers are delivery systems for the
delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures …

[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases

MAH Abusalah, H Chopra, A Sharma… - Biomedicine & …, 2023 - Elsevier
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …

Recent advances in nanomaterials-based targeted drug delivery for preclinical cancer diagnosis and therapeutics

H Tiwari, N Rai, S Singh, P Gupta, A Verma, AK Singh… - Bioengineering, 2023 - mdpi.com
Nano-oncology is a branch of biomedical research and engineering that focuses on using
nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively …

Advances with lipid-based nanosystems for siRNA delivery to breast cancers

MA Subhan, N Filipczak, VP Torchilin - Pharmaceuticals, 2023 - mdpi.com
Breast cancer is the most frequently diagnosed cancer among women. Breast cancer is also
the key reason for worldwide cancer-related deaths among women. The application of small …

Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival

C Fieni, C Sorrentino, SL Ciummo, A Fontana… - … & Molecular Medicine, 2024 - nature.com
The development of selective and nontoxic immunotherapy targeting prostate cancer (PC) is
challenging. Interleukin (IL) 30 plays immunoinhibitory and oncogenic roles in PC, and its …

Overview of solid lipid nanoparticles in breast cancer therapy

K Mo, A Kim, S Choe, M Shin, H Yoon - Pharmaceutics, 2023 - mdpi.com
Lipid nanoparticles (LNPs), composed of ionized lipids, helper lipids, and cholesterol,
provide general therapeutic effects by facilitating intracellular transport and avoiding …

Optical nanobiosensor-based point-of-care testing for cardiovascular disease biomarkers

T Vairaperumal, CC Huang, PY Liu - ACS Applied Bio Materials, 2023 - ACS Publications
Cardiovascular disease is a global health threat, and detecting cardiac biomarkers is
essential for early-stage diagnosis and personalized treatment. Traditional approaches have …

RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment

X Shan, Z Zhao, P Lai, Y Liu, B Li, Y Ke, H Jiang… - Nature …, 2024 - nature.com
Metabolic dysfunction-associated steatohepatitis (MASH) poses challenges for targeted
delivery and retention of therapeutic proteins due to excess extracellular matrix (ECM). Here …

[HTML][HTML] Receptor-targeted nanomedicine for cancer therapy

A Prajapati, S Rangra, R Patil, N Desai, VGSS Jyothi… - Receptors, 2024 - mdpi.com
Receptor-targeted drug delivery has been extensively explored for active targeting of
therapeutic moiety in cancer treatment. In this review, we discuss the receptors that are …

Unleashing the potential: Designing antibody-targeted lipid nanoparticles for industrial applications with CMC considerations and clinical outlook

S Wang, H Wang, A Drabek, WS Smith… - Molecular …, 2023 - ACS Publications
Antibody-targeted lipid nanoparticles (Ab-LNPs) are rapidly gaining traction as multifaceted
platforms in precision medicine, adept at delivering a diverse array of therapeutic agents …